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summary
Purpose: We report a case of a 30 years old Indian sailor with microcytic anemia (Hb 9.9), persistent ab-
dominal pain, emesis, dark stool, hyperchromic urine, latent jaundice and asthenia. Lead intoxication was 
conf irmed (blood lead value of 102 µg/dL). The patient assumed Ayurvedic medicines in the previous months. 
Ayurveda is an ancient form of Indian traditional popular medicine aiming to re-establish health and body 
function through herbal preparations, heavy metals are often added. Our purpose was to treat the patient 
and to establish the source of poisoning. Methods: After testing blood and urine lead concentration of oth-
er 3 crew members and analyzing over than 150 products used on the ship professional exposure was ex-
cluded. We analyzed the two   Ayurvedic drugs assumed by the patient with an Inductively Coupled Plasma 
Mass Spectrometry. The patient underwent three chelation cycles with Calcium Disodium Ethylenediami-
netetraacetic acid (EDTA) while monitoring blood and urinary lead levels. Results: The f inal blood lead 
level at discharge, after three chelation cycles, was 36.27 µg/dL. One of the two drugs contained extremely 
high concentrations of lead and mercury. The three different mixtures of this preparation showed lead concen-
trations of 12,638.54 mg/kg (Sample 2A), 23,043.02 mg/kg (Sample 2B), 21,352.97 mg/kg (Sample 2C); 
these levels are much higher than the highest values reported in literature for the indian soil (32 mg/kg). 
Conclusions: This case and similar cases raise the safety alert on complementary and alternative medicines; 
Ayurvedic medicine users should be carefully informed about potential risks and signs of poisoning.
 open access www.lamedicinadellavoro.it
Ayurveda is a form of traditional medicine native 
to India which has been practiced extensively in the 
subcontinent for more than 2000 years (1) and is 
used approximately by 80% of Indians (2). Recently, 
Ayurveda is gaining popularity as a complementary 
treatment. As a result, approximately 40% of adults 
in the United States report using complementary 
and alternative medicines (CAMs) (3). Increasing 
numbers could probably be observed in countries 
where Ayurveda is not yet so practiced, due to work 
migration (4). Ayurvedic formulations are based 
on herbal products but often include heavy metals, 
intentionally added to restore health and normal 
body function, as part of Rasa Shastra (5).
Contrary to allopathic medicine, manufacturing 
and access to CAMs are poorly regulated. Ayur-
vedic medicines in Western countries are not con-
sidered as drugs. Rather, as food supplements, they 
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are available without medical prescription through 
multiple sources including the Internet. Although 
even some physicians overlook possible risks asso-
ciated with ayurvedic tratments, it is estimated that 
over 20% of ayurvedic medications distributed by 
U.S. and Indian companies contain toxic metals (5); 
some preparations have been found to contain lead 
and/or mercury exceeding by 100 to 10,000 times 
the limits set for food (6).
From 2000 to 2003, the Centers for Disease 
Control reported 12 cases of lead poisoning in 
adults associated with Ayurvedic medication intake 
occurring in five different states (7). Less than 20 
scientific reports on lead poisoning could be found 
through scientific literature analysis of the past 10 
years (Mesh key words: “lead poisoning” AND 
“Ayurvedic medication”). The contamination of 
herbal formulations with metals presents potential 
health risks. The most common diagnosis is lead 
poisoning, which is frequently revealed by the in-
vestigation of anaemia.
Lead is considered as an inhibitor of haem synthe-
sis and a haemolysis promotor. Lead related anaemia 
can be normocytic or microcytic mainly due to the 
inhibition of delta aminolevulinic acid dehydratase 
and ferrochelatase.  As a result, protoporphyrin ac-
cumulates in erythrocytes forming zinc protopor-
phyrin. Lead levels exceeding 30 μg/dL determine 
elevated blood levels of free erythrocyte protopor-
phyrin and zinc protoporphyrin. Anaemia develops 
when blood lead levels exceed 50 to 60 μg/dL. Lead 
has a prevalent urinary excretion, the non-excreted 
portion being deposited in bones. Other characteris-
tic manifestations of lead poisoning include gastro-
intestinal and neurological symptoms (8).
In Western countries, industrial lead exposure 
control played a key role in minimizing job exposure 
(9) and in the last decades cases of saturnism requir-
ing hospitalization were mostly non-occupational, 
due to contaminated wine (10). We recently had the 
chance to admit to our Department a young Indian 
sailor with high levels of blood lead. During a resi-
dential period in his country from 14/10/2019 to 
31/01/2020 the patient presented lower back pain 
due to the recurrence of a pilonidal cyst, previously 
experienced in 2008 and 2013. In both cases, he was 
treated with Ayurvedic topic medications while, for 
this last recrudescence, his Ayurvedic practitioner 
(referred to as “shaman”) prescribed an oral formu-
lation. In February, the patient returned to Italy 
and rejoined his crew in Genoa (Italy) with whom 
he carried out different maintenance activities on 
board. At the beginning of March, due to persistent 
abdominal pain, he underwent gastroenterological 
examination and a few days later he presented em-
esis, dark stool, hyperchromic urine, latent jaundice 
and asthenia and was referred to Hospital Galliera 
in Genoa. The first blood test showed hemoglobin 
9.9 mg/dL, total bilirubin 3.5 mg/dL (direct biliru-
bin 1.1 mg/dL), SGOT 90 mg/dL, SGPT 160 mg/
dL (Table 1). Esophagogastroduodenoscopy was 
negative. The only finding in the chest and abdomi-
nal CT was hepatic steatosis. At the end of April, 
the patient underwent haematological counselling 
for microcytic anaemia associated with hyperfer-
ritinemia and reticulocytosis. A screening for lead 
poisoning showed a blood lead value of 102 µg/dL. 
On 8/6/2020, after passing the COVID-19 hos-
pital prevention protocol (1), the patient came to 
our observation: during the previous three months 
the ayurvedic treatment had been withdrawn, and 
symptoms gradually disappeared thereafter. In April 
and May 2020, the patient did not undergo any 
blood tests.
During the first hospitalization in our depart-
ment, we excluded occupational exposure. Blood 
and urine lead levels of other crew members were 
in a normal range and over 150 products used on 
board resulted lead free. At the admission in our 
department, the patient was asymptomatic, and the 
main haemato-chemical values were within the re-
spective refence intervals (Table 1-2), whereas the 
basal lead values in blood (B-Pb) and urine samples 
were still high (74.61 µg/dL and 94.7 µg/L, respec-
tively). 
In consideration of the B-Pb (12, 13), a chela-
tion protocol was initiated with the administration 
of Calcium Disodium Ethylenediaminetetraacetic 
acid (EDTA) 2 g in 500 ml of physiological solu-
tion (PS) in 12 hours for the first day, followed by 
four days of EDTA 1 g at the same dilution and 
infusion speed. Hematic and urinary lead variation 
during three chelation cycles is reported in Figure 
1. B-Pb at discharge was 36.27 µg/dL. 
ciocan et al164
The sailor referred that he used to assume an 
oral intake of 1 dose (about one spoon) of “product 
1” mixed with 1 dose of each of the three parts of 
“product 2”, twice a day (products 1, 2A, 2B, 2C).
Our Industrial Toxicology Laboratory analysed 
0.5 g of each product sample: we added 2.5 ml of 
concentrated Nitric Acid to each sample and after 
1h of treatment in a furnace at 80°C we made up to 
25 ml, we diluted the solutions (1:1000) and used 
an inductively coupled plasma mass spectrometry 
(ICP-MS) searching for arsenic, mercury, copper, 
chromium, manganese, iron, nickel and lead.
Finally, we compared our values with data in the 
literature regarding the highest values in different 
soil samples of Uttar Pradesh, our patient’s home 
region; results are summarized in Table 3 (14-16).
ConClusion
Laboratory findings confirmed the source of poi-
soning. The absence of mercury-related symptoms 
despite a high content of mercury in the samples 
2A, 2B and 2C could be explained by the species 
of the metal, as inorganic mercury is known to be 
poorly absorbed by the gastrointestinal tract. A pe-
culiar aspect of this case is that haemoglobin (Hb) 
usually takes several months to return to normal 
values in the absence of chelation while our patient 
had a fast normalization of Hb values in less than 
three months, before arrival in our hospital (Ta-
ble 2). This case and similar cases of lead poison-
ing caused by Ayurveda practice raise the safety 
alert of complementary and alternative medicines. 
The increasing number of users of Ayurvedic drugs 
Table 1 - Blood values of biomarkers of lead intoxication
At admission 
(08/06/2020)
At discharge  
(10/07/2020)
Reference values
ALA Dehydratase, U.I./ml 11.5 20.8 20.0 – 40-0
Blood Lead Level (ICP-MS), μg/dL   74.61 42.2 0.50 – 10.0
Baseline Urinary Lead (ICP-MS), μg/dL 94.70 93.6    5.00 –  30.00
Total Hemoglobin, g/dL 12.80 13.9 14.00 – 18.00
Zinc protophorphyrin – ZP,  μg/dL Hb   0.66 0.52 < 2.00
ALAU - Delta-aminolevulinic acid, mg/g creat 14.89 1.96 < 4.50
CPU – Coproporphyrin, μg/dL creat 423 3 < 100.00








Creatinine, mg/dL 0.9 0.93 1.04 0.60 – 1.30
Sodium, mEq/L 139 143 142 135 – 145
Potassium, mEq/L 4.6 4.4 3.8 3.5 – 5.0
Leukocytes, No.x109/L 9.73 6.51 5.99 4.00 – 10.00
Erythrocytes, No.x1012/L 3.23 4.58 5.12 4.50 – 5.80
Haemoglobin, g/dL 8.40 13.0 14.1 13.5 – 18.00
Hematocrit, % 25.5 41.0 42.4 40.0 – 52.0
Mean corpuscular volume, fL 78.9 90 83 79 – 96
Platelet Count, No.x109/L 300 270 223 140 – 450
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Figure 1 - Blood and urine lead levels during chelation therapy
Table 3 - Concentration of analysed elements in the environment and in the ayurvedic drug taken by the patient
 




sample product  
1 (mg/kg)
Concentration in 
sample product  
2A (mg/kg)
Concentration in 
sample product  
2B (mg/kg)
Concentration in 
sample product  
2C (mg/kg)
Lead 520 2.31 12,638.54 23,043.02 21,352.97
Mercury 0.49 2.54 89,076.70 126,640.27 145,710.64
Arsenic 12 0.35 134.94 103.98 122.30
Copper 323 3.96 1,511.04 2,168.79 2,356.80
Chromium 0.9 1.14 8.86 7.68 12.04
Manganese 45.1 26.34 146.74 172.53 149.75
Iron 389 288.04 14,990.34 16,498.80 15,767.59
Nickel 100 0.66 7.24 8.02 9.21
* Values referred to different sites of Uttar Pradesh region, except for mercury that is referred to whole India
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worldwide calls for establishing standardized label-
ling and regulations of manufacturing and distri-
bution of these treatments. Moreover, consumers 
should be properly informed about potential risks 
and clinical signs of poisoning. We believe it is im-
portant to stress these concepts and to be extremely 
vigilant, as the number of case reports is dwindling 
in the last ten years, while this work proves that the 
problem persists.
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la raCColta Completa della nostra rivista diventa digitale
Procede la digitalizzazione della raccolta completa della nostra rivista (“Il Lavoro” dal 1901 al 1924 e poi  
“La Medicina del Lavoro” dal 1925 in poi). Oltre agli ultimi 20 anni, già accessibili nel sito della casa editrice  
(www.lamedicinadellavoro.it), i volumi pubblicati nei primi 50 anni (1901-1950) sono ora disponibili sia in 
formato fotografico (.tiff o .jpg) che come documento ricercabile (.pdf ). Tutti i volumi disponibili saranno 
online e ad accesso libero subito dopo la firma di una convenzione tra la struttura (SIML - Società Italiana 
di Salute sul Lavoro) e l’Università degli Studi di Milano (proprietaria dell’archivio storico della rivista). Nel 
frattempo, chi intendesse realizzare progetti sulla storia della medicina del lavoro utilizzando i volumi pubblicati 
nella prima metà del XX secolo è pregato di contattarci (redazione[at]lamedicinadellavoro.it). 
the Complete ColleCtion of our journal goes digital
The digitalization of the complete collection of our journal (“Il Lavoro” and then “La Medicina del Lavoro” 
from the 16th volume onwards) is advancing. In addition to the last 20 years already accessible from the 
journal’s site (www.lamedicinadellavoro.it), all the volumes published during the first 50 years (1901-1950) are 
now available both in photographic format (.tiff and .jpg) and as a searchable document (.pdf ). Open access will 
be provided soon once an agreement is signed between the property (SIML – Italian Society of Occupational 
Health) and the University of Milan (owner of the journal’s historical archive). Meanwhile, scholars willing to 
implement projects on the history of Occupational Medicine relying on the volumes published during the first 
half of the 20th   century are kindly requested to contact us (redazione[at]lamedicinadellavoro.it).
